Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-administration of HZ/su and quadrivalent influenza vaccine in adults aged 50 years and older
2013-000372-15Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Zoster vaccine recombinant and Fluarix Quadrivalent in herpes zoster (HZ) and influenza (2 arms), sponsored by GSK. Started Jul 2013; status: completed.
02
Drugs
Zoster vaccine recombinantFluarix Quadrivalent
03
Conditions
herpes zoster (HZ)influenza
Beyond the preview
Go deeper on 2013-000372-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000372-15.